Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
0.8488
-0.1612 (-15.96%)
At close: Oct 7, 2026, 4:00 PM EDT
0.8544
+0.0056 (0.66%)
After-hours: Oct 7, 2026, 7:30 PM EDT
Pomdoctor Revenue
Pomdoctor had revenue of 185.00M CNY in the half year ending June 30, 2026, with 23.20% growth. This brings the company's revenue in the last twelve months to 410.45M, up 11.88% year-over-year. In the year 2025, Pomdoctor had annual revenue of 399.91M with 16.74% growth. That makes Pomdoctor the world's 26,513th largest company by revenue and 3,646th in the United States.
Revenue (ttm)
410.45M CNY
Revenue Growth
+11.88%
P/S Ratio
0.12
Revenue / Employee
2,487,548 CNY
Employees
165
Market Cap
6.56M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 399.91M | 57.36M | 16.74% |
| Dec 31, 2024 | 342.56M | 37.70M | 12.37% |
| Dec 31, 2023 | 304.85M | 59.64M | 24.32% |
| Dec 31, 2022 | 245.22M | 29.83M | 13.85% |
| Dec 31, 2021 | 215.38M | 74.18M | 52.53% |
| Dec 31, 2020 | 141.21M | -44.33M | -23.89% |
| Dec 31, 2019 | 185.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Johnson & Johnson | 97.93B |
| Eli Lilly and Company | 79.67B |
| Merck & Co. | 66.57B |
| AbbVie | 64.39B |
| Bolt Biotherapeutics | 4.70M |
| IceCure Medical | 3.95M |
| Aclarion | 83.77K |
POM News
- 7 days ago - POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization - PRNewsWire
- 13 days ago - POMDOCTOR LIMITED Highlights Differentiated "Hardware + AI + Payment" Healthcare Infrastructure Model - PRNewsWire
- 27 days ago - POMDOCTOR LIMITED to Participate in H.C. Wainwright's 28th Annual Global Investment Conference - PRNewsWire
- 5 weeks ago - POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy - PRNewsWire
- 1 month ago - POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine - PRNewsWire
- 2 months ago - POMDOCTOR LIMITED Highlights Four-Tier Diversified Revenue Structure - PRNewsWire
- 2 months ago - POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities - PRNewsWire
- 2 months ago - PomDoctor regains Nasdaq compliance - TheFly